| 0 (0%) | 12-05 10:03 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 51.28 |
1-year : | 53.99 |
| Resists | First : | 43.91 |
Second : | 46.22 |
| Pivot price | 42.84 |
|||
| Supports | First : | 40.15 |
Second : | 33.41 |
| MAs | MA(5) : | 43.9 |
MA(20) : | 43.1 |
| MA(100) : | 48.48 |
MA(250) : | 0 | |
| MACD | MACD : | -0.5 |
Signal : | -0.7  |
| %K %D | K(14,3) : | 65.5 |
D(3) : | 72.5 |
| RSI | RSI(14): 41.8 |
|||
| 52-week | High : | 74.69 | Low : | 40.15 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ CNMD ] has closed above bottom band by 41.6%. Bollinger Bands are 19% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 44.99 - 45.21 | 45.21 - 45.39 |
| Low: | 43.11 - 43.41 | 43.41 - 43.65 |
| Close: | 43.82 - 44.27 | 44.27 - 44.64 |
Fri, 05 Dec 2025
Conmed Exits Gastroenterology Products to Focus on Core Markets - TipRanks
Fri, 05 Dec 2025
CONMED Corp Announces Strategic Exit from Gastroenterology Product Lines - TradingView
Fri, 05 Dec 2025
CONMED (NYSE: CNMD) to leave gastroenterology, speed Gore VIABIL exit and flag 2026 EPS dilution - Stock Titan
Thu, 04 Dec 2025
Here's Why You Should Add CONMED Stock to Your Portfolio Now - TradingView
Tue, 02 Dec 2025
Are Investors Undervaluing CONMED (CNMD) Right Now? - Yahoo Finance
Tue, 02 Dec 2025
Will CNMD stock deliver stable dividends - July 2025 Recap & Safe Investment Capital Preservation Plans - Newser
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 31 (M) |
| Shares Float | 31 (M) |
| Held by Insiders | 0.5 (%) |
| Held by Institutions | 117.1 (%) |
| Shares Short | 2,250 (K) |
| Shares Short P.Month | 2,100 (K) |
| EPS | 2.04 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 32.56 |
| Profit Margin | 4.7 % |
| Operating Margin | 10.8 % |
| Return on Assets (ttm) | 4.1 % |
| Return on Equity (ttm) | 6.5 % |
| Qtrly Rev. Growth | 6.6 % |
| Gross Profit (p.s.) | 24.57 |
| Sales Per Share | 43.59 |
| EBITDA (p.s.) | 7.29 |
| Qtrly Earnings Growth | -94.4 % |
| Operating Cash Flow | 168 (M) |
| Levered Free Cash Flow | 177 (M) |
| PE Ratio | 20.69 |
| PEG Ratio | 0 |
| Price to Book value | 1.3 |
| Price to Sales | 0.97 |
| Price to Cash Flow | 7.83 |
| Dividend | 0.2 |
| Forward Dividend | 0 |
| Dividend Yield | 0.4% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|